全文获取类型
收费全文 | 81977篇 |
免费 | 7930篇 |
国内免费 | 6176篇 |
专业分类
耳鼻咽喉 | 602篇 |
儿科学 | 858篇 |
妇产科学 | 635篇 |
基础医学 | 8453篇 |
口腔科学 | 1314篇 |
临床医学 | 10285篇 |
内科学 | 10885篇 |
皮肤病学 | 663篇 |
神经病学 | 4082篇 |
特种医学 | 3268篇 |
外国民族医学 | 44篇 |
外科学 | 8799篇 |
综合类 | 16774篇 |
现状与发展 | 19篇 |
一般理论 | 16篇 |
预防医学 | 6517篇 |
眼科学 | 1821篇 |
药学 | 9200篇 |
83篇 | |
中国医学 | 5358篇 |
肿瘤学 | 6407篇 |
出版年
2024年 | 309篇 |
2023年 | 1184篇 |
2022年 | 3052篇 |
2021年 | 3815篇 |
2020年 | 3088篇 |
2019年 | 2452篇 |
2018年 | 2622篇 |
2017年 | 2536篇 |
2016年 | 2328篇 |
2015年 | 3792篇 |
2014年 | 4733篇 |
2013年 | 4668篇 |
2012年 | 6885篇 |
2011年 | 7639篇 |
2010年 | 5301篇 |
2009年 | 4479篇 |
2008年 | 4996篇 |
2007年 | 4996篇 |
2006年 | 4631篇 |
2005年 | 4273篇 |
2004年 | 3002篇 |
2003年 | 2694篇 |
2002年 | 2321篇 |
2001年 | 1827篇 |
2000年 | 1656篇 |
1999年 | 1345篇 |
1998年 | 858篇 |
1997年 | 839篇 |
1996年 | 641篇 |
1995年 | 563篇 |
1994年 | 433篇 |
1993年 | 310篇 |
1992年 | 282篇 |
1991年 | 228篇 |
1990年 | 212篇 |
1989年 | 219篇 |
1988年 | 164篇 |
1987年 | 152篇 |
1986年 | 120篇 |
1985年 | 114篇 |
1984年 | 58篇 |
1983年 | 39篇 |
1982年 | 34篇 |
1981年 | 29篇 |
1980年 | 17篇 |
1979年 | 20篇 |
1978年 | 12篇 |
1973年 | 12篇 |
1972年 | 17篇 |
1970年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
12.
In this immunohistochemical study, the authors detected the expression of c-myc in keratinocytes (ECK) from 30 psoriatics before and after Qingdai Compound Capsule (QDCC) treatment and 12 normal subjects for control. The results showed that the ECK of patients before treatment was significantly higher than that in the normal control group, and its level was correlated with histopathological changes of affected skin. After treatment the ECK was normalized. It is believed that QDCC could decrease the ECK in psoriatics and this effect was probably mediated by inhibiting c-myc expression. This study provided an experimental evidence for the application of QDCC in treating psoriasis. 相似文献
13.
改良超滤对婴幼儿心脏手术输血的影响 总被引:4,自引:1,他引:3
目的 观察改良超滤技术在婴幼儿体外循环心血管手术中对输血及术后出血的影响。方法 6 0例接受体外循环下心血管手术的先天性心脏病患儿 ,均分为对照组 (不接受任何超滤 )、常规超滤组 (CUF组 )和改良超滤组 (MUF组 )。观察术中库血用量、血浆用量、血球压积的变化及术后2 4h出血量 ,并用SSPS/PC进行统计学处理。结果 MUF组库血用量、血浆用量、术后 2 4h出血量显著低于对照组和CUF组 (P <0 0 1) ,且滤出水量明显多于CUF组 (P <0 0 1)。结论 在婴幼儿心血管手术中 ,改良超滤可有效排出体内水分 ,提高血球压积 ,明显减少输血及术后出血 ,是节约用血的重要手段之一。 相似文献
14.
15.
王霞芳治疗小儿泄泻的经验 总被引:1,自引:0,他引:1
小儿泄泻的病因病机因其自身稚阴稚阳的生理特点而较成人为多发,泄泻久甚,易耗伤气液,甚至出现伤阴伤阳的重证、变证。故要重视及时正确地治疗,以防产生危候。王霞芳老师治疗小儿泄泻首先注重审证求因,在精确辨证基础上立法选方而施治,并在病变过程中法随症变,灵活化裁,刻刻护卫脾气胃津,斡旋脾胃气机,重视清浊升降枢机作用。尝用葛根、扁豆衣、荷叶等轻灵升清之品,宣发清阳,泄泻自和。对屡治不愈、迁延日久者,王师认为应辨证细致,选药精到,且又及时而适当地参入止涩药物。固肠止涩法之运用,必须具备苔净,腹软,溲通,无表证和里积等条件,方为合宜。 相似文献
16.
Gerald S. Lipshutz Harish Mahanty Sandy Feng Ryutaro Hirose Peter G. Stock Sang-Mo Kang rew M. Posselt Chris E. Freise 《American journal of transplantation》2005,5(2):366-373
With the introduction of more potent immunosuppressive agents, rejection has decreased in simultaneous pancreas/kidney transplant (SPK) recipients. However, as a consequence, opportunistic infections have increased. The purpose of this report is to outline the course of SPK patients who developed polyomavirus-associated nephropathy (PVAN). A retrospective review of 146 consecutive SPK recipients from January 1, 1996 to December 31, 2002 was performed. Immunosuppression, rejection and development of PVAN were reviewed. Nine patients were identified. All received induction with either OKT3 or thymoglobulin. Immunosuppression included tacrolimus/cyclosporine, MMF/azathioprine and sirolimus/prednisone. Two patients were treated for kidney rejection prior to the diagnosis of PVAN. Time to diagnosis was an average of 359.3 days post-transplantation. Immunosuppression was decreased but five ultimately lost function. However, none developed pancreatic abnormalities as demonstrated by normal glucose and amylase. Two underwent renal retransplantation after PVAN diagnosis and both have normal kidney function. PVAN was the leading cause of renal loss in SPK patients in the first 2 years after transplantation and is a serious concern for SPK recipients. The pancreas, however, is spared from evidence of infection, and no pancreatic rejection occurred when immunosuppression was decreased. 相似文献
17.
18.
19.
Alex Zacharek Jieli Chen Xu Cui Ang Li Yi Li Cynthia Roberts Yifan Feng Qi Gao Michael Chopp 《Journal of cerebral blood flow and metabolism》2007,27(10):1684-1691
Bone marrow stromal cells (MSCs) increase vascular endothelial growth factor (VEGF) expression and promote angiogenesis after stroke. Angiopoietin-1 (Ang1) and its receptor Tie2 mediate vascular integrity and angiogenesis as does VEGF and its receptors. In this study, we tested whether MSC treatment of stroke increases Ang1/Tie2 expression, and whether Ang1/Tie2 with VEGF/ vascular endothelial growth factor receptor 2 (VEGFR2) (Flk1), in combination, induced by MSCs enhances angiogenesis and vascular integrity. Male Wistar rats were subjected to middle cerebral artery occlusion (MCAo) and treated with or without MSCs. Marrow stromal cell treatment significantly decreased blood-brain barrier (BBB) leakage and increased Ang1, Tie2, and occludin (a tight junction protein) expression in the ischemic border compared with MCAo control. To further test the mechanisms of MSC-induced angiogenesis and vascular stabilization, cocultures of MSCs with mouse brain endothelial cells (MBECs) or astrocytes were performed. Supernatant derived from MSCs cocultured with MBECs significantly increased MBEC expression of Ang1/Tie2 and Flk1 compared with MBEC alone. Marrow stromal cells cocultured with astrocytes also significantly increased astrocyte VEGF and Ang1/Tie2 expression compared with astrocyte culture alone. Conditioned media from MSCs alone, and media from cocultures of MSCs with astrocytes or MBECs, all significantly increased capillary tube-like formation of MBEC compared with control Dulbecco's modified Eagle's medium media. Inhibition of Flk1 and/or Ang1 significantly decreased MSC-induced MBEC tube formation. Knockdown of Tie2 expression in MBECs significantly inhibited MSC-induced tube formation. Our data indicate MSC treatment of stroke promotes angiogenesis and vascular stabilization, which is at least partially mediated by VEGF/Flk1 and Ang1/Tie2. 相似文献
20.
改良W形回肠代膀胱术的疗效观察(附36例报告) 总被引:5,自引:0,他引:5
目的 :探讨改良W形回肠代膀胱术的疗效。方法 :对 36例膀胱肿瘤患者行根治性膀胱切除、W形回肠代膀胱术 ,并对术式进行改进。结果 :36例手术时间平均 4 .2h。术后 31例随访 4~ 19个月 ,平均 10 .6个月 ,无严重并发症 ,均无瘤生存。患者一般于术后 3周自主可控性排尿 ,日间尿控率为 10 0 % ,术后 3、6、12个月夜间尿失禁发生率分别为 2 2 .5 %、11.1%及 6 .2 %。术后 6个月尿动力学检查膀胱容量 (36 0± 30 )ml,最大尿流率 (13.6± 2 .6 )ml/s,剩余尿量 (11.5± 5 .8)ml,充盈期膀胱压力明显低于尿道闭合压。新膀胱造影发现新膀胱呈球形 ,完全位于盆腔 ,未见输尿管反流。B超及IVU检查发现原上尿路积水 4例均明显减轻 ,其余未发现输尿管狭窄和上尿路积水征象。无高氯性酸中毒 ,肾功能正常。结论 :改良W形回肠代膀胱术手术时间短 ,操作简单 ,创伤轻 ,并发症少 ;新膀胱容量大 ,内压低 ,顺应性好 ,功能接近于正常膀胱 ,保持原位排尿 ,明显提高了患者术后生活质量 ,值得临床推广应用。 相似文献